It's mind boggling for Gets to rise from 9 cents to 4.02 today by merely announcing intention to diversify into Glove. I don't see why Salcon can go South upon announcing acquisition of an existing Glove company. Your patience will definitely be rewarded
Covid-19 vaccine dampens sentiment on glove counters in morning trade KUALA LUMPUR (Nov 16): Glove stocks were headed lower in Bursa Malaysia's morning trading session today due to the news flow of Covid-19 vaccine progress, which dampened sentiment on the counters. As at the time of writing, glove stocks were among the top losers today. At 11.53am, Hartalega Holdings Bhd, being the second top loser, was down 4.29% or 66 sen at RM14.72, bringing its market capitalisation lower to RM50.54 billion. It saw some 2.78 million shares traded. In the fourth place was Supermax Corp Bhd, which fell 5.24% or 46 sen to RM8.32, with a market value of RM22.72 billion. More than seven months after the World Health Organization (WHO) declared the Covid-19 outbreak in China a “public health emergency of international concern”, the global economy continues to reel from the impact of the virus. Meanwhile, Top Glove Corp Bhd, which bought back 8.94 million or 0.72% of its shares for RM69.9 million in the open market last Friday, dropped 3.98% or 31 sen to RM7.47, valuing the stock at RM61.47 billion. The counter was the seventh biggest loser as at the time of writing. The smaller players were also not spared from the selling pressure. Kossan Rubber Industries Bhd lost 4.2% or 28 sen to RM6.38, Careplus Group Bhd fell 6.58% or 20 sen to RM2.84, and Comfort Gloves Bhd shed 4.71% or 19 sen to RM3.84. The Healthcare Index was dragged down by the glove stocks, declining by 1.75% or 69.68 points to 3,921.47. Last week, Pfizer and its German partner BioNTech announced that their experimental Covid-19 vaccine was more than 90% effective with no serious safety concerns based on initial trial results. They also estimated that they can roll out up to 50 million doses this year for 25 million people and produce 1.3 billion doses in 2021.
Govt has communicated with 10 Covid-19 vaccine producers, says Khairy KUALA LUMPUR (Nov 16): The government has communicated with 10 Covid-19 vaccine producers following a notification by the World Health Organization (WHO) that there are 11 Covid-19 vaccine candidates in phase 3 clinical trial (as of Nov 13). Science, Technology and Innovation Minister Khairy Jamaluddin said communications with eight of the producers was made directly, while the other two was through the Covid-19 Vaccine Global Access Facility (COVAX). He said some of the discussions are in the final stage and an official announcement would be made when everything has been finalised. “The discussion covers aspects of cooperation in various stages of vaccine development such as R&D (research and development), exchange of scientists, fill and finish development (transfer of technology, logistics, cold chain), including the purchase of vaccines (finished products) as a guarantee of access to vaccine supply for the country," he said during the questions for oral answers session in the Dewan Rakyat today. He was responding to a question from Chan Foong Hin (Pakatan Harapan-Kota Kinabalu) who wanted to know whether the ministry had made any order to import vaccines from companies from China, such as Cansino, Sinovac and Sinopharm, or the UK, such as AstraZeneca, and whether the ministry would set the order of priority for Covid-19 vaccination as being done in Indonesia. Khairy said through participation in COVAX, Malaysia would have access to the supply of Covid-19 vaccine of 10% of the country's population and the government was working to get another 60% to meet the national immunisation target for herd immunity to up to 70 per cent of the country's population. The government, he said, was also working to get vaccine access as early as the first or second quarter of next year depending on the approval from the National Pharmaceutical Regulatory Agency (NPRA). He said the NPRA will ensure that a vaccine passes the stipulated strict conditions, covering its safety and effectiveness through data on the clinical trial that was conducted. Meanwhile, on the list of immunisation priorities, Khairy said the Special Committee on Covid-19 Vaccine Supply Access (JKJAV), set up on Oct 14 , had agreed to divide it into three groups, namely the frontliners, involving staff of the Ministry of Health (MoH) and agencies not under the MoH, such as the police, the Malaysian Armed Forces, Immigration Department and others, in the first group. The second is for high-risk groups, such as individuals with co-morbid and seniors citizens, and the third involves other adult population. Details of the groups are being made and the announcement is expected to be made during the first quarter of next year.
With this acquisition Salcon can immediately ride the business with minimal risks and can have better option to assess situation on expansion before spending more millions;
1. The transaction are genuine and honest 2. Salcon not a goreng stock/management 3. Very low risk for company to diversify and venture to gloves. 4. Very good acquisition indeed Spend only RM29M for controlling stake Ready and workable factory Mature and skillful factory so expanding is not a problems 5. The company and the management are expert in gloves business and providing consultancy and setting up gloves factory worldwide 6. Own expertise to expand factory capacity. This alone will save company millions in consultancy and construction. 7. RM10M profit guarantee after tax will have big impact on Salcon (51% Salcon) 8. Producing Latex examination, surgical gloves, Nitrile gloves with FDA approval will save time. 8. Already has existing clients (critical success factor) so will be better then many new startup 9. Small shares issue, price has not gone up much and being very long in downtrend/consolidation mode. 10. Water is raising industry with big potential especially in Selangor where Salcon has very good business connection and proven track records. Soon government and rakyat has to realise they got to pay more for uninterrupted quality water supply.
no need to worry...I've been monitoring this stocks for months...the same pattern...down..then up, then down again...sideways....last week's was not even the highest...last month's was higher...chill and relax.
Most likely will need egm and shareholders approval as its a diversification of business ... So gonna wait at least four months .....
Salcon wishes to furnish the following additional information as requested by Bursa Malaysia Securities Berhad via its letter dated 13 November 2020: 1. Whether shareholders’ approval will be sought for Salcon Berhad’s diversification into the glove business pursuant to Paragraph 10.13 of the Main Market Listing Requirements. The Company take cognizance of Paragraph 10.13 of the Main Market Listing Requirements and would assess the requirements pursuant to Paragraph 10.13 of the Main Market Listing Requirements on the diversification into the glove business. The Company would seek shareholder’s approval in the future when the Company is expected to trigger the threshold of Paragraph 10.13 of the Listing Requirements.
2. The total capital and investment outlay to be incurred by JREMT for the additional 12 production line (“Expansion”), its sources of funding (including the breakdown) and to quantify the portion to be borne by Salcon Berhad and/or NJSB. The proposed funding for the additional 12 production lines is to be financed by the mix of the bank borrowings to be raised by JREMT and the shareholders advances proportionately to its shareholdings. The quantum of the shareholders advances is only to be determined after the finalisation of bank borrowings. . 3. The current production capacity and output of JREMT and the expected production capacity and output after the Expansion. The current production and output capacity of JREMT is 336 million pieces per year and the expected production and output capacity after the expansion is 3.05 billion pieces annually.
am still holding tight this cina apek co of course, its new glove JR eng. acquisition instantly revenue enhancing vs AT, or Mah Sing still at fancy level. cina ah pek always diam diam ubi berisi ma. not kompang like ah pu nei nei ma.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
kfliau
1,977 posts
Posted by kfliau > 2020-11-16 13:22 | Report Abuse
It's mind boggling for Gets to rise from 9 cents to 4.02 today by merely announcing intention to diversify into Glove. I don't see why Salcon can go South upon announcing acquisition of an existing Glove company. Your patience will definitely be rewarded